Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Qilian International Holding Group Limited Releases 2022 Chairman Letter 2022-01-11 20:00
Sana Biotechnology, IASO Biotherapeutics, and Innovent Biologics Announce Non-Exclusive License Agreement for Clinically Validated BCMA CAR Construct 2022-01-11 05:30
Trajan Group acquires Neoteryx LLC 2022-01-11 00:00
CARsgen Announces CT041 CAR T-cell Product Candidate Granted RMAT Designation by the FDA 2022-01-10 21:50
SERIAL INNOVATOR, EITAN KONSTANTINO JOINS GENESIS MEDTECH AS CTO OF VASCULAR INTERVENTIONS FRANCHISE 2022-01-07 23:00
KAZIA THERAPEUTICS TO PRESENT AT HC WAINWRIGHT BIOCONNECT CONFERENCE 2022-01-07 21:00
100% Recovery-GoldenBiotech Announces Topline Results from Unblinded COVID-19 Trial for Oral New Drug Antroquinonol in Hospitalized Mild, Moderate and Severe Patients 2022-01-07 18:53
Li Jian Quan, Chairman of WINNER MEDICAL Co., Ltd., Was Invited to "DIALOGUE PROGRAM" in CCTV-2 (China Central Television) 2022-01-07 17:47
InnoCare to Attend Upcoming Investor Conferences to Share Latest Company Development 2022-01-07 08:30
LISCure Biosciences announces research collaboration with Mayo Clinic for rare liver diseases 2022-01-06 22:00
I-Mab Announces Senior Management Team Share Purchase Plan 2022-01-06 21:00
Alterity Therapeutics Granted New US Patent for Compounds for Neurodegenerative Diseases Including Parkinson's and Alzheimer's 2022-01-06 20:30
AKESO'S CADONILIMAB (PD-1/CTLA-4 BI-SPECIFIC ANTIBODY) COMBINED WITH IVONESCIMAB (PD-1/VEGF BI-SPECIFIC ANTIBODY) COMBINED WITH OR WITHOUT CHEMOTHERAPY OBTAINED APPROVAL TO INITIATE A PHASE Ib/II CLINICAL TRIAL FOR THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER 2022-01-06 19:00
Nuance Pharma acquires Sino Health to further strengthen its commercial capabilities and expand pipelines 2022-01-06 14:45
Ascentage Pharma to Present at the J.P. Morgan 40th Annual Healthcare Conference 2022-01-06 08:30
Adlai Nortye Announces First Patient Dosed in Phase I Clinical Trial of the orally available, small-molecule PD-L1 inhibitor AN4005 for Advanced Tumors 2022-01-06 01:00
Metavention Completes U.S. Enrollment in Groundbreaking Feasibility Study to Treat Type 2 Diabetes 2022-01-05 22:00
Alterity Therapeutics to Present at the H.C. Wainwright BIOCONNECT Virtual Conference 2022-01-05 20:45
PRISM BioLab, enters multi-project drug discovery collaboration with Roche and Genentech 2022-01-05 09:00
BIORCHESTRA, SK Biopharmaceuticals collaborate to develop miRNA-targeted therapeutics 2022-01-05 08:07
1 145 146 147 148 149 433